Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 530 | 1,992 | N/A | N/A |
| TOTAL | $606 | $2,066 | $N/A | $N/A |
| Non-Current Assets | ||||
| TOTAL | $N/A | $0 | $N/A | $N/A |
| Total Assets | $606 | $2,066 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 3,546 | 731 | N/A | N/A |
| Accounts payable and accrued liabilities | 104 | 337 | 0 | 0 |
| Accrued Expenses | 134 | 155 | N/A | N/A |
| Other current liabilities | N/A | 500 | N/A | N/A |
| TOTAL | $3,783 | $1,723 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | N/A | 553 | N/A | N/A |
| TOTAL | $N/A | $553 | $N/A | $N/A |
| Total Liabilities | $3,783 | $2,276 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 2,353 | 2,353 | N/A | N/A |
| Retained earnings | -28,080 | -24,843 | N/A | N/A |
| TOTAL | $-3,178 | $-210 | $N/A | $N/A |
| Total Liabilities And Equity | $606 | $2,066 | $0 | $0 |